MassMutual Private Wealth & Trust’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.82K Sell
82
-6
-7% -$252 ﹤0.01% 1703
2026
Q1
$2.83K Buy
88
+25
+40% +$925 ﹤0.01% 1877
2025
Q4
$2.65K Hold
63
﹤0.01% 1916
2025
Q3
$2.16K Buy
63
+50
+385% +$1.43K ﹤0.01% 1960
2025
Q2
$351 Sell
13
-45
-78% -$1.3K ﹤0.01% 2264
2025
Q1
$1.72K Buy
58
+21
+57% +$800 ﹤0.01% 1966
2024
Q4
$1.47K Hold
37
﹤0.01% 1924
2024
Q3
$1.26K Sell
37
-19
-34% -$535 ﹤0.01% 1792
2024
Q2
$1.21K Buy
56
+50
+833% +$1.05K ﹤0.01% 1767
2024
Q1
$133 Buy
+6
New +$146 ﹤0.01% 2018
2023
Q4
Sell
-36
Closed -$804 2099
2023
Q3
$804 Buy
+36
New +$926 ﹤0.01% 1738
2022
Q4
Sell
-81
Closed -$1K 1868
2022
Q3
$1K Buy
+81
New +$1.82K ﹤0.01% 1552
2022
Q2
Sell
-22
Closed -$1K 1726
2022
Q1
$1K Buy
+22
New +$629 ﹤0.01% 1446

Other funds holding VCYT

MassMutual Private Wealth & Trust's VCYT Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its Veracyte (VCYT) stake by 6.8% in Q2 2026, selling an estimated $252 and leaving 82 shares worth $4.82K. The position accounts for ﹤0.01% of the portfolio, ranked #1703.

MassMutual Private Wealth & Trust first reported a position in VCYT in Q1 2022 and has held it in 13 quarters since. 87 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • MassMutual Private Wealth & Trust held 82 shares of Veracyte worth $4.82K as of Q2 2026.
  • MassMutual Private Wealth & Trust sold 6 Veracyte shares in Q2 2026, an estimated $252.
  • Veracyte made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1703 holding.
  • MassMutual Private Wealth & Trust first reported a position in Veracyte in Q1 2022 and has held it in 13 quarters since.
  • 87 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.